Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.81
-0.22 (-1.57%)
At close: May 14, 2026, 4:00 PM EDT
13.81
0.00 (0.00%)
After-hours: May 14, 2026, 4:10 PM EDT
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $400.76 million as of May 14, 2026. Its market cap has increased by 224.50% in one year.
Market Cap
400.76M
Enterprise Value
360.36M
1-Year Change
224.50%
Ranking
Category
Stock Price
$13.81
Market Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has increased from $289.30M to $400.76M, an increase of 38.53%. That is a compound annual growth rate of 2.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 408.00M | -10.37% |
| Dec 31, 2025 | 455.20M | 273.42% |
| Dec 31, 2024 | 121.90M | -38.50% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 440.15M |
| ADC Therapeutics | 436.27M |
| Larimar Therapeutics | 429.04M |
| Autolus Therapeutics | 425.83M |
| PureTech Health | 424.75M |
| Invivyd | 421.38M |
| Century Therapeutics | 413.01M |
| Monopar Therapeutics | 410.97M |